Masimo Corporation (NASDAQ:MASI) has earned an average rating of “Hold” from the nine analysts that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and four have given a buy recommendation to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $97.00.

Several research analysts recently commented on the company. BidaskClub downgraded Masimo Corporation from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. BTIG Research raised Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a research note on Monday, August 14th. Stifel Nicolaus reissued a “buy” rating and issued a $108.00 price objective (up from $105.00) on shares of Masimo Corporation in a research note on Thursday, August 3rd. Zacks Investment Research raised Masimo Corporation from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th. Finally, Roth Capital increased their price objective on Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th.

Masimo Corporation (NASDAQ:MASI) traded up 0.08% on Wednesday, hitting $84.98. 285,750 shares of the company were exchanged. The stock’s 50-day moving average price is $85.78 and its 200-day moving average price is $90.95. The stock has a market capitalization of $4.41 billion, a P/E ratio of 13.93 and a beta of 0.84. Masimo Corporation has a 52-week low of $53.78 and a 52-week high of $104.71.

Masimo Corporation (NASDAQ:MASI) last posted its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.12. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The firm had revenue of $192.90 million during the quarter, compared to the consensus estimate of $189.03 million. During the same period in the prior year, the company earned $0.57 EPS. The firm’s revenue was up 11.8% compared to the same quarter last year. On average, equities research analysts anticipate that Masimo Corporation will post $2.80 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Brokerages Set Masimo Corporation (MASI) PT at $97.00” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/09/23/brokerages-set-masimo-corporation-masi-pt-at-97-00.html.

In other Masimo Corporation news, insider Rick Fishel sold 15,000 shares of the firm’s stock in a transaction on Tuesday, July 11th. The stock was sold at an average price of $92.85, for a total value of $1,392,750.00. Following the completion of the sale, the insider now directly owns 35,022 shares of the company’s stock, valued at approximately $3,251,792.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Sanford Fitch sold 14,000 shares of the firm’s stock in a transaction on Thursday, June 29th. The stock was sold at an average price of $92.06, for a total value of $1,288,840.00. Following the completion of the sale, the director now directly owns 90,249 shares of the company’s stock, valued at $8,308,322.94. The disclosure for this sale can be found here. Insiders sold a total of 126,000 shares of company stock valued at $11,732,930 over the last ninety days. Corporate insiders own 16.60% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the business. Fortaleza Asset Management Inc. acquired a new stake in shares of Masimo Corporation in the 2nd quarter worth $106,000. Neuburgh Advisers LLC increased its stake in shares of Masimo Corporation by 6.4% in the 1st quarter. Neuburgh Advisers LLC now owns 1,328 shares of the medical equipment provider’s stock worth $124,000 after acquiring an additional 80 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Masimo Corporation by 32.2% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,782 shares of the medical equipment provider’s stock worth $166,000 after acquiring an additional 434 shares during the last quarter. Dubuque Bank & Trust Co. increased its stake in shares of Masimo Corporation by 3.4% in the 2nd quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock worth $170,000 after acquiring an additional 61 shares during the last quarter. Finally, Bancorpsouth Inc. acquired a new stake in shares of Masimo Corporation in the 1st quarter worth $203,000. 83.21% of the stock is owned by institutional investors and hedge funds.

Masimo Corporation Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Analyst Recommendations for Masimo Corporation (NASDAQ:MASI)

Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.